CLINICAL TRIALS PROFILE FOR DARIDOREXANT HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for DARIDOREXANT HYDROCHLORIDE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT04250506 ↗ | A Study to Assess the Effect of Single Doses of Daridorexant on Electrocardiogram Parameters in Healthy Subjects | Completed | Idorsia Pharmaceuticals Ltd. | Phase 1 | 2020-02-28 | A study to assess the effect of single doses of daridorexant on electrocardiogram parameters in healthy subjects |
| NCT04390334 ↗ | A Study in Healthy Male Subjects to Investigate the Effect of Famotidine and Efavirenz on the Way the Body Takes up, Distributes, and Gets Rid of Daridorexant. | Completed | Idorsia Pharmaceuticals Ltd. | Phase 1 | 2020-05-13 | A study in healthy male subjects to investigate the effect of famotidine and efavirenz on the way the body takes up, distributes, and gets rid of daridorexant. |
| NCT05423717 ↗ | Dose-finding Study Assessing the Efficacy, Safety, and Pharmacokinetics of Daridorexant in Subjects Aged 10 to < 18 Years With Insomnia Disorder | Not yet recruiting | Idorsia Pharmaceuticals Ltd. | Phase 2 | 2022-07-01 | This study assesses the efficacy, safety, and pharmacokinetics of multiple-dose oral administration of daridorexant in pediatric subjects aged 10 to < 18 years with insomnia disorder. |
| NCT05458193 ↗ | A Study to Investigate the Effects of Daridorexant on Nighttime Breathing in Patients With Shallow or Paused Breath During Sleep | Not yet recruiting | Idorsia Pharmaceuticals Ltd. | Phase 1 | 2022-07-29 | A study on the effects of daridorexant on nighttime respiratory function in patients with severe obstructive sleep apnea (OSA). |
| NCT05480475 ↗ | A Study to Examine the Effect of Daridorexant on the Way the Body Absorbs, Distributes, and Gets Rid of Dabigatran and Rosuvastatin in Healthy Male Subjects | Not yet recruiting | Idorsia Pharmaceuticals Ltd. | Phase 1 | 2022-09-02 | A study to examine the effect of daridorexant on the way the body absorbs, distributes, and gets rid of dabigatran and rosuvastatin in healthy male subjects |
| NCT05480488 ↗ | A Study to Examine the Effect of Daridorexant on the Way the Body Absorbs, Distributes, and Gets Rid of Midazolam and Warfarin in Healthy Male Subjects | Not yet recruiting | Idorsia Pharmaceuticals Ltd. | Phase 1 | 2022-08-06 | A study to examine the effect of daridorexant on the way the body absorbs, distributes, and gets rid of midazolam and warfarin in healthy male subjects |
| NCT05597020 ↗ | A Post Approval Study to Investigate the Efficacy of Daridorexant in Subjects With Insomnia and Comorbid Nocturia | Not yet recruiting | Idorsia Pharmaceuticals Ltd. | Phase 4 | 2022-10-30 | A post approval study to investigate the efficacy of daridorexant in subjects with insomnia and comorbid nocturia |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for DARIDOREXANT HYDROCHLORIDE
Condition Name
Condition MeSH
Clinical Trial Locations for DARIDOREXANT HYDROCHLORIDE
Trials by Country
Clinical Trial Progress for DARIDOREXANT HYDROCHLORIDE
Clinical Trial Phase
Clinical Trial Sponsors for DARIDOREXANT HYDROCHLORIDE
Sponsor Name
